Allozymes
PrivateLast Round
Series A
May 14, 2024
Total Funding Raised
$20.26M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Allozymes is a biotechnology company that develops custom enzymes for pharmaceutical, food, and industrial manufacturing using proprietary microfluidics and machine learning technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allozymes Comparables
Compare Allozymes with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zymvol Biomodeling | 82% | |
| EnginZyme | 82% | |
| Quantumzyme | 81% |
Allozymes Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 14, 2024 | ||||
| Seed | Jul 6, 2021 | ||||
| Accelerator | Dec 4, 2019 |
Key People
Founding team and executive leadership
Allozymes Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Transpose Platform Management | Seed |
| Xora Innovation | Seed, Series A |
| ID Capital | Series A |
| Transpose Platform | Series A |
| Thia Ventures | Series A |
| Entrepreneurs First | Seed, Series A |
| SOSV | Seed, Accelerator, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 1407% MoM, reaching 1.5K.
Allozymes Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Allozymes's valuation, stock price, and market status.
Is Allozymes a public or private company?
Allozymes is a private company.
What is the current stock price of Allozymes?
Allozymes is a private company with no public stock price. No recent secondary market data is available.
How much is Allozymes worth (valuation)?
Valuation information for Allozymes is not publicly available.
Can I buy Allozymes stock?
Allozymes shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Allozymes's last funding round?
Allozymes's most recent funding round was Series A on May 13, 2024.
Who are the main investors in Allozymes?
Key investors in Allozymes include Xora Innovation, Seventure Partners.
Will Allozymes IPO soon?
No public IPO plans have been announced for Allozymes.
How can I track Allozymes secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Allozymes's secondary market activity and sign up for updates.